微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 7.55% | -4.43% | 70.43% | 43/158 | 4.06% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 4.43% | -10.69% | 80.08% | 43/158 | 2.54% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.46% | -6.46% | -65.55% | 49/158 | 2.29% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 7.14% | 25.48% | -9.62% | 45/158 | -1.07% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 7.9% | 4.08% | 59.27% | 41/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 4.96% | 34.42% | 88.59% | 42/158 | 1.5% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.63% | 24.64% | -53.78% | 46/158 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 5.69% | 19.79% | -25.03% | 71/158 | 0.75% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 7.59% | 22.82% | 105.69% | 49/158 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 3.69% | 20.2% | 74.88% | 62/158 | 2.26% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.11% | 10.47% | -55.58% | 55/158 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 4.75% | 13.1% | -23.14% | 79/158 | 0.86% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 6.18% | 18.39% | 101.3% | 66/158 | 4.52% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 3.07% | 7.72% | 60.73% | 77/158 | 2.98% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.91% | 19.38% | -54.52% | 69/158 | 2.5% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 4.2% | 29.63% | -19.54% | 89/158 | 3.68% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 5.22% | -9.38% | 83.16% | 70/158 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 2.85% | -5.94% | 78.13% | 75/158 | 4.25% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1.6% | 25% | -50.62% | 60/158 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 3.24% | -7.95% | -43.75% | 100/158 | 2.77% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 5.76% | 28% | 90.1% | 62/158 | 7.65% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 3.03% | 0.33% | 136.72% | 72/158 | 5.07% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.28% | 36.17% | -63.64% | 77/158 | 2.47% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 3.52% | -14.36% | -21.78% | 100/158 | 7.11% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 4.5% | -12.11% | 49.01% | 74/158 | 7.24% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 3.02% | 23.77% | 221.28% | 67/158 | 4.61% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.94% | 16.05% | -77.13% | 80/158 | 2.58% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 4.11% | 25.3% | -19.73% | 91/158 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 5.12% | 36.17% | 109.84% | 64/158 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 2.44% | 37.85% | 201.23% | 77/158 | 5.6% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.81% | 39.66% | -75.3% | 67/158 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 3.28% | 73.54% | -12.77% | 90/158 | 7.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 3.76% | 31.47% | 112.43% | 59/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 1.77% | 46.28% | 205.17% | 71/158 | 3.86% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.58% | 0% | -69.31% | 70/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 1.89% | -36.58% | -33.92% | 87/158 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 2.86% | -13.07% | 136.36% | 58/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 1.21% | -13.57% | 108.62% | 64/158 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 0.58% | 56.76% | -80.54% | 58/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |
| 2014-12-31 | 2.98% | 63.74% | -9.42% | 80/158 | 12.37% | 广生堂 | 15.57% | 行业排名> |
| 2014-09-30 | 3.29% | 34.29% | 135% | 53/158 | 7.53% | 退市金泰 | 97.4% | 行业排名> |
| 2014-06-30 | 1.4% | 52.17% | 278.38% | 52/158 | -4.93% | 奥翔药业 | 93.52% | 行业排名> |
| 2014-03-31 | 0.37% | 0% | -79.67% | 57/158 | 2.13% | 退市金泰 | 47.24% | 行业排名> |